iSpecimen (ISPC) Cash & Current Investments (2020 - 2026)

iSpecimen's Cash & Current Investments history runs 7 years deep, the most recent figure standing at $2.8 million for Q1 2026.

• In Q1 2026, Cash & Current Investments rose 260.23% year-over-year to $2.8 million; the TTM figure through Mar 2026 stood at $2.8 million (up 260.23% YoY), while the FY2025 annual figure was $6.9 million, up 266.31% from the prior year.
• Cash & Current Investments was $2.8 million for Q1 2026 at iSpecimen, down from $6.9 million in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $26.1 million in Q1 2022 to a low of $588775.0 in Q2 2025.
• Historically, Cash & Current Investments has averaged $8.1 million across 5 years, with a median of $5.0 million in 2023.
• The sharpest annual moves came in 2024 and 2025: Cash & Current Investments tumbled 76.81% in 2024, then jumped 266.31% in 2025.
• A 5-year view of Cash & Current Investments shows it stood at $15.3 million in 2022, then slumped by 67.3% to $5.0 million in 2023, then tumbled by 62.47% to $1.9 million in 2024, then surged by 266.31% to $6.9 million in 2025, then slumped by 59.03% to $2.8 million in 2026.
• The last three Cash & Current Investments figures came in at $2.8 million (Q1 2026), $6.9 million (Q4 2025), and $2.8 million (Q3 2025), per Business Quant data.